If local anesthetic systemic toxicity is suspected during a regional anesthesia, what is the recommended treatment?

If local anesthetic systemic toxicity is suspected during a regional anesthesia, what is the recommended treatment?

• A. Lipid emulsion therapy
• B. Increase local anesthetic dose
• C. Give epinephrine only
• D. No treatment required

Answer: (A)

Suspected local anesthetic systemic toxicity is treated most effectively with lipid emulsion therapy because the lipid trap rapidly lowers free circulating levels of the lipophilic local anesthetic, reducing its toxic effects on the brain and heart. The lipid emulsion provides an intravascular lipid phase that binds the drug (the “lipid sink” effect), pulling it away from target tissues and helping restore cardiac conduction and neurological function. It also supplies fatty acids that the exhausted heart can use for energy during the crisis, supporting hemodynamics. Start lipid therapy promptly alongside general supportive care: secure the airway and provide oxygen, manage seizures with benzodiazepines if they occur, and follow ACLS principles for cardiac/respiratory instability. The typical approach is to give an initial bolus of 20% lipid emulsion (about 1.5 mL/kg) IV over a minute, then begin an infusion (roughly 0.25 mL/kg/min), with additional boluses or adjustments as needed based on response. Use vasopressors cautiously, avoiding large doses of epinephrine when possible, and rely on other agents as guided by the clinical situation. Do not delay lipid therapy while awaiting other treatments or test results.

Suspected local anesthetic systemic toxicity is treated most effectively with lipid emulsion therapy because the lipid trap rapidly lowers free circulating levels of the lipophilic local anesthetic, reducing its toxic effects on the brain and heart. The lipid emulsion provides an intravascular lipid phase that binds the drug (the “lipid sink” effect), pulling it away from target tissues and helping restore cardiac conduction and neurological function. It also supplies fatty acids that the exhausted heart can use for energy during the crisis, supporting hemodynamics.

Start lipid therapy promptly alongside general supportive care: secure the airway and provide oxygen, manage seizures with benzodiazepines if they occur, and follow ACLS principles for cardiac/respiratory instability. The typical approach is to give an initial bolus of 20% lipid emulsion (about 1.5 mL/kg) IV over a minute, then begin an infusion (roughly 0.25 mL/kg/min), with additional boluses or adjustments as needed based on response. Use vasopressors cautiously, avoiding large doses of epinephrine when possible, and rely on other agents as guided by the clinical situation. Do not delay lipid therapy while awaiting other treatments or test results.